Pfizer Says Its COVID-19 Vaccine Is <br />95% Effective With No Safety Concerns.<br />Pfizer and BioNTech revealed the news on Wednesday after conducting a final data analysis.<br />According to the drugmakers, 28 days after receiving the first dose, the vaccine became highly effective across all ages, races and ethnicities.<br />The vaccine, known as BNT162b2, was also over 94% effective in elderly people, who are at a high risk of developing more severe COVID-19 symptoms. .<br />The announcement comes just two days <br />after Moderna revealed that its vaccine <br />had a 94.5% success rate.<br />Both vaccines utilize mRNA as their delivery systems to provoke an immune response.<br />but Pfizer's vaccine needs to be kept at a much colder temperature of minus 94 degrees Fahrenheit.<br />Pfizer is still confident that it can adequately distribute the vaccine and has launched a pilot delivery program in <br />Rhode Island, Texas, New Mexico and Tennessee. .<br />We are hopeful that results from this vaccine delivery pilot will serve as the model for other U.S. states and international governments, <br />as they prepare to implement effective <br />COVID-19 vaccine programs, Pfizer, via statement.<br />Pfizer intends to submit an emergency use authorization application to the FDA "within days."
